Commitments and Contingencies - Additional Information (Detail) - USD ($) |
6 Months Ended | ||||
|---|---|---|---|---|---|
Oct. 30, 2024 |
Oct. 25, 2024 |
Jun. 30, 2026 |
Dec. 31, 2025 |
Oct. 23, 2024 |
|
| Loss Contingencies [Line Items] | |||||
| Underwriting commitments | The underwriters were entitled to an underwriting discount of $0.20 per Public Unit, or $3,839,806 in the aggregate, $3,500,000 of which was paid on October 25, 2024 and $339,806 of which was paid on October 30, 2024 in connection with the closing of the partially exercised over-allotment option granted to the underwriters of the Initial Public Offering. In addition, in connection with the closing of the Initial Public Offering on October 25, 2024 and the closing of the partially exercised over-allotment option on October 30, 2024, $0.35 per Public Unit sold, or $6,719,660 in the aggregate, became payable to the underwriters for deferred underwriting commissions. The deferred underwriting fee will be paid to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. | ||||
| Under writing discount per unit | $ 0.2 | ||||
| Under writing discount | $ 339,806 | $ 3,500,000 | $ 3,839,806 | ||
| Under writing commission per unit paid | $ 0.35 | ||||
| Payment of underwriting commission | $ 6,719,660 | ||||
| Deferred legal fees business combination | $ 299,088 | $ 299,088 | |||
| Risks and uncertainties in entity's business | The impact of the above actions on the world economy is not determinable as of the date of these unaudited condensed financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these unaudited condensed financial statements. The Company’s ability to consummate an initial Business Combination, or the operations of a target business with which the Company ultimately consummates an initial Business Combination, may be materially and adversely affected by these military actions and related sanctions. In addition, the Company’s ability to consummate a Business Combination may be dependent on the ability to raise equity and debt financing which may be impacted by these events, including as a result of increased market volatility, or decreased market liquidity in third-party financing being unavailable on terms acceptable to the Company or at all. These unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty. | ||||
| Over-Allotment Option [Member] | |||||
| Loss Contingencies [Line Items] | |||||
| Sale of stock, number of shares issued in transaction | 925,971 | ||||
| Founder shares [member] | |||||
| Loss Contingencies [Line Items] | |||||
| Share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period | 231,492 | ||||
| Underwriting agreement [member] | |||||
| Loss Contingencies [Line Items] | |||||
| Option for under writers to purchase additional units term | 45 days | ||||
| Additional units that can be purchased to cover over allotments | 1,699,029 | 2,625,000 | |||
| Shares issued, price per share | $ 10 | ||||
| Proceeds from issuance or sale of equity | $ 16,990,290 |